Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
Experimental Therapeutics
-
-
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
-
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
-
Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma
-
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma
-
Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer
-
Paclitaxel in Treating Women With Recurrent Solid Tumors
-
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
-
Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
-
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Categories
Alliance Committee
Browse by Year